PROVIDER FILE · The briefing room

Shed Review: What Its GLP-1 Subscription Terms Do—and Do Not—Settle

Shed advertises multiple weight-management options and ongoing support, but automatic renewals, refund limits and conflicting price disclosures deserve a close read before enrollment.

The most consequential part of joining Shed may not be choosing an injection, pill or other formulation. It may be establishing exactly what subscription you are buying. Its public documentation describes automatic renewals, a cancellation deadline and nonrefundable membership fees after treatment approval. Meanwhile, some product pages give conflicting membership charges and medication prices. For a prospective customer, the central contract question is whether the checkout agreement clearly reconciles those differences before any payment becomes difficult to recover.

Shed facilitates telehealth weight-management services, including branded GLP-1 products and compounded preparations, alongside other wellness offerings. This review examines public documentation consulted October 19, 2026, rather than a purchased treatment experience. Its focus is the relationship between the advertised service and the obligations attached to enrollment: who provides care, what payment covers, what renews, and what happens if approval, a refill or cancellation does not proceed as expected. Documented options are not guarantees of a prescription or availability in every state.

At a glance

Platform versus clinician
Shed Holdings, LLC operates the platform; its terms assign clinical services to independent professional entities and their licensed providers.
Sources: [8]
Automatic renewal
Medication programs renew automatically, with billing every 28 days or monthly depending on the program.
Sources: [8]
Cancellation deadline
The terms require cancellation at least 72 hours before the next billing date to avoid the upcoming charge.
Sources: [8]
Compounded injection prices
Displayed one-month plans are $199 per month for compounded semaglutide injections and $299 per month for compounded tirzepatide injections; longer plans show lower monthly figures.
Sources: [9] [6]
Branded-product fee conflict
Wegovy and Zepbound pages contain both $99 Shed membership/provider fee disclosures and separate offers showing a $125 monthly membership.
Sources: [11] [7]

The contract starts with three different responsibilities

Shed’s homepage calls the business a telehealth clinic, but its terms define a narrower role. Shed Holdings, LLC owns and operates a telehealth and communications website; the company says it is not a medical group and does not provide medical advice, diagnosis or treatment. Independent, physician-owned or licensed professional entities and their affiliated licensed healthcare providers handle clinical evaluations, prescriptions, treatment plans and follow-up schedules. That distinction matters when deciding who can resolve a treatment concern versus an account dispute.

The public documentation reviewed does not identify those clinical entities by legal name or independently establish individual licenses. Nor does a list of pharmacy partners establish which pharmacy will serve a particular patient. Before enrolling, a customer can reasonably ask for the treating entity’s identity, the clinician’s role and the dispensing pharmacy’s details. Our guide to mapping platform, clinician and pharmacy responsibilities explains why these are separate questions rather than interchangeable descriptions of the same service.

Shed also markets hair health, sexual wellness and longevity services. Its weight-management catalog includes compounded semaglutide and tirzepatide injections, branded options, sublingual products, a metformin/naltrexone/topiramate capsule and MIC plus B12 injections. This breadth makes the actual product agreement important: a general membership description is not enough to establish the formulation, route, included services or pharmacy payment arrangement for every offering. The terms governing one program should not automatically be treated as the complete agreement for another.

Sources: [8] [5]

Approval is a clinical step, not a checkout promise

Shed advertises an initial form taking about five minutes, covering health history and preferred administration method. Although some marketing says an appointment is unnecessary, the homepage FAQ qualifies that message: depending on the state and treatment, a licensed medical provider may conduct a virtual visit or review the online assessment without a live appointment. The terms leave the clinical modality and suitability decision to the independent providers. Completing a form therefore does not establish approval, a particular prescription or an appointment-free process.

Subscribers must be at least 18 and located in a U.S. state where services are available. Shed says it offers telehealth in all 50 states, while noting that treatment availability varies with medical and regulatory requirements. The terms further tie provider, medication and visit-format availability to the state where the patient is physically located during the visit. Someone traveling between states should clarify that requirement before assuming an existing account guarantees uninterrupted access to the same service.

The Wegovy catalog describes adults with a BMI of at least 30, or at least 27 with a weight-related condition. That product description is not automatic approval, and the reviewed documentation does not establish equivalent criteria for every compounded offering. It also does not establish a general clinical-review turnaround or universal laboratory requirements. The useful pre-enrollment question is what assessment, visits and documentation this particular program requires—and whether any payment is collected before those steps are complete.

Sources: [5] [8] [4]

A lower monthly figure does not settle the commitment

Shed’s compounded injection pages provide concrete plan prices. Semaglutide is displayed at $199 per month for a one-month plan, $179 per month for six months and $159 per month for twelve months. Tirzepatide is $299, $269 and $239 per month for the corresponding plan lengths. These are not interchangeable month-to-month offers. The tables alone do not settle whether longer plans are collected upfront, billed in installments or subject to additional early-exit obligations, and plan duration does not establish shipment quantity.

The route-specific sections list semaglutide-containing liquid drops starting at $229 per month, including medication, supplies, member support and free shipping. Sublingual lozenges are advertised month-to-month starting at $199 per month, with member support and free shipping. Their pages also mix in Wegovy content and other headline pricing, so those distinct product sections are the more useful reference—not proof that every nearby price describes drops or lozenges. A written agreement should name the exact product and route.

Shed says GLP-1 plan pricing stays the same when a provider increases the prescribed dose. That is a provider pricing claim, not a resolution of every fee or renewal question. The homepage also says insurance is unnecessary and eligible HSA/FSA cards may pay for qualifying services, subject to the plan. Before paying, use the distinctions in monthly prices versus billing commitments to establish the first collection, subsequent interval, total obligation and services included in the selected offer.

Selected displayed prices and the contract questions they leave open
OfferingDisplayed price and conditionsClarification needed
Compounded semaglutide injections$199/month for 1 month; $179/month for 6 months; $159/month for 12 monthsCollection schedule, shipment quantity and early-cancellation terms
Compounded tirzepatide injections$299/month for 1 month; $269/month for 6 months; $239/month for 12 monthsCollection schedule and obligations attached to the longer plan
Semaglutide-containing liquid dropsStarting at $229/month; medication, supplies, support and free shipping includedExact formulation and applicable renewal agreement
Sublingual semaglutide lozengesMonth-to-month, starting at $199/month; support and free shipping advertisedFull inclusions and whether other minimum terms apply
Foundayo oral orforglipronStarting at $149/month for new cash-pay patients, excluding a $125 Shed membership/provider feeFee recurrence, subsequent medication pricing and pharmacy charges
Sources: [9] [6] [5] [13] [3]

Branded-product disclosures need reconciliation

Wegovy’s page says approved patients can access semaglutide as a once-daily pill or weekly injection pen, dispensed by a pharmacy. One disclosure advertises starting medication prices of $149 per month for the pill and $199 per month for the pen for new cash-pay patients, excluding a $99 Shed membership/provider fee. Medication is paid separately to the pharmacy. Another block lists $349–499 for medication plus $125 per month for membership, without specifying the period covered by that medication range.

Zepbound’s product-specific page describes tirzepatide in a vial, pharmacy fulfillment and home delivery if approved. Its specific pricing disclosure starts at $349 per month for new cash-pay patients, excluding a $99 Shed membership/provider fee, with medication paid separately to the pharmacy. Elsewhere, it lists $349–499 for medication plus $125 monthly membership. The page also contains an opening $149-per-month claim plus $125 membership. These competing figures cannot responsibly be reduced to one verified starting package price.

Foundayo is described by Shed as once-daily oral orforglipron. Its disclosed price starts at $149 per month for new cash-pay patients, excludes a $125 Shed membership/provider fee paid to Shed, and sends medication payment separately to the dispensing pharmacy. These new-patient starting figures do not establish later charges. For all three branded offerings, request a product-specific written quote identifying presentation, first charge, recurring fees and pharmacy payment. The reviewed documentation does not resolve which conflicting Wegovy or Zepbound fee governs.

Sources: [11] [7] [10]

Renewal, cancellation and refunds are separate events

The terms state that all medication programs are subscriptions that renew automatically. Billing may occur every 28 days or monthly, depending on the program; those intervals are not equivalent. Customers must cancel at least 72 hours before the next billing date to avoid the upcoming charge. Later cancellations apply to the following month. The documented self-service path is the Patient Portal, then “My Treatments,” then “Manage Subscription.” Keeping the renewal date and cancellation confirmation is more useful than relying on a calendar-month assumption.

Cancellation does not itself establish a refund right. Membership fees become nonrefundable once a patient is approved for treatment; if a licensed provider does not approve treatment, the membership fee is refunded. That statement concerns membership fees, not an unrestricted promise to return every possible payment. The terms also reference a two-month minimum commitment within the refund provisions. Its application across individual plans is not clear in the reviewed documentation, which includes an omitted intermediate portion of the terms.

That minimum deserves an explicit answer before enrollment, particularly where a product page says “month-to-month” or shows a one-month plan. Neither a package label nor the existence of a cancellation button settles every remaining financial obligation. Ask which minimum applies, what remains payable after cancellation, and whether stopping renewal also stops an already initiated pharmacy order. The practical distinctions in cancellation notice, renewal dates and order status are especially relevant when billing and clinical or shipping schedules do not line up.

Sources: [8] [3]

Refill obligations can affect money even without a shipment

One particularly consequential provision concerns required patient actions. If medication is not shipped because a patient has not submitted a refill request or attended a required visit, the terms say that month remains ineligible for a refund. Shed may, at its discretion, offer a one-time credit toward a future shipment after the actions are completed, provided the subscription stays active. A discretionary future credit is not a cash refund, and remaining subscribed can itself create further billing obligations.

Shed’s advertised guarantee is also conditional: the tirzepatide page ties it to eligibility, required check-ins and adherence to the treatment plan. The reviewed documentation does not provide the complete procedure, exclusions or refund calculation for the advertised 120-day guarantee. It should not be treated as an unconditional trial period. Before relying on it, request the full guarantee terms and ask how they interact with nonrefundable membership fees, refill requirements, the minimum commitment and cancellation deadlines.

The larger contract issue is whether clinical tasks and billing obligations remain synchronized. A subscription can renew even when a patient has not completed a required step, according to the no-shipment provision. Establish how reminders arrive, where refill forms appear and who confirms that a visit is necessary. Our explanation of refund guarantees and their exclusions can help separate eligibility for a guarantee from ordinary cancellation and from a credit offered at the company’s discretion.

Sources: [8] [6]

Pharmacy fulfillment brings its own unanswered questions

The terms list Strive Compounding Pharmacy, Promise Pharmacy, DCA Pharmacy, Everwell Pharmacy, Custom Ivy Pharmacy and Boothwyn Pharmacy as partners. They also permit transfers between partner pharmacies. This documents possible fulfillment relationships, not the pharmacy assigned to an individual prescription or independent verification of its licensing. The terms make no guarantee about product origin and contemplate shipments from the United Kingdom, Canada or other locations. U.S. pharmacy references in marketing therefore do not establish a universal U.S.-origin commitment.

Standard shipping is advertised at no additional cost, but the reviewed material does not establish a general GLP-1 arrival deadline. A seven-to-ten-business-day estimate appears for women’s hair treatments after provider approval; it should not be borrowed as a GLP-1 delivery promise or counted from initial registration. Before payment, ask which pharmacy will dispense, where the shipment originates, when tracking becomes available and who handles a missing or compromised package. Dispensing, dispatch and arrival are different milestones.

FDA guidance adds a specific delivery safeguard: do not use an injectable GLP-1 product that arrives warm or with insufficient refrigeration; contact the provider or dispensing pharmacy. FDA also recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations are not FDA approved or subject to FDA premarket review, but nonapproval alone does not establish clinical inequivalence or prove that a particular provider is unsafe.

Sources: [5] [12] [8] [6] [1]

Ongoing support should be defined by type, not slogan

Shed’s tirzepatide page advertises health coaching, unlimited provider follow-ups, health courses and free access to Pivot, an app for logging doses, side effects, habits and progress. The homepage describes support from a dedicated health coach and dietitian, with follow-up appointments available as needed. Separately, the terms describe certain memberships as including one 15-minute virtual coaching appointment monthly and say the membership fee is separate from medication. Those descriptions should be reconciled for the selected program rather than combined into a universal benefit package.

Free text-based coaching may include AI-generated responses, according to Shed, which says a licensed coach monitors and reviews communications. That is distinct from a medical provider visit and from a scheduled coaching appointment. The member portal offers routes to a health coach, medical provider, nursing team, treatment resources and account or order support. These are useful documented contact paths, but the public material does not establish a universal response-time commitment or prove that every type of interaction is included without additional conditions.

Product descriptions also need boundaries. Shed markets semaglutide-containing drops and sublingual lozenges, including its own absorption claims, while those pages mix in branded-product content. Neither nearby approval language nor studies of another formulation establish outcomes for those products. FDA approval concerns a specific product, not Shed as a platform. Contract clarity should therefore include the prescribed formulation and route as well as support access; a well-described membership is not, by itself, evidence of clinical effectiveness.

Sources: [13] [3] [6] [5] [8] [1] [2]

Questions & answers

Can I cancel Shed immediately before the next charge?

The documented deadline is at least 72 hours before the next billing date. Later requests apply to the following month. The portal path is “My Treatments,” then “Manage Subscription.” Confirm the actual renewal date because the program may bill every 28 days rather than monthly, and cancellation does not automatically create a refund.

Sources: [8]
Will Shed refund me if treatment is not approved?

Its terms say the membership fee will be refunded if a licensed provider does not approve treatment. Once treatment is approved, membership fees are nonrefundable. This is a membership-fee provision, not a blanket refund promise for every charge. The reviewed documentation does not establish when refunded money would reach a bank account.

Sources: [8]
Which Wegovy or Zepbound membership fee should I expect?

The public pages do not resolve that reliably. Both contain a $99 Shed membership/provider fee disclosure and another offer showing $125 monthly membership, alongside differing medication figures. Ask Shed for written confirmation of the exact product presentation, medication price, membership charge, billing interval and pharmacy payment before accepting an offer.

Sources: [11] [7]
Does a six- or twelve-month plan require upfront payment?

The compounded injection tables show monthly-equivalent prices for those plan lengths, but do not by themselves establish the collection schedule. They also do not establish supply quantity or complete early-cancellation consequences. Request the payment schedule and applicable minimum commitment; the terms’ reference to a two-month minimum is not clearly mapped to every plan.

Sources: [9] [6] [8]
What happens if I miss a refill form or required visit?

The terms say a month is not refundable when missing required actions prevents shipment. Shed may offer a one-time future credit after the actions are completed, but that is discretionary and requires the subscription to remain active. Ask support to identify outstanding requirements rather than assuming that no shipment means no financial obligation.

Sources: [8]
Does Shed guarantee that my medication ships from the United States?

No such guarantee appears in the reviewed terms. They list U.S. pharmacy partners but also disclaim a guaranteed place of origin and contemplate shipments from other countries. Confirm the assigned dispensing pharmacy and shipment origin for your prescription. The partner list alone does not establish which pharmacy will handle your order.

Sources: [8]

Our assessment

Shed documents a broad weight-management catalog, portal-based support, included standard shipping and a practical self-service cancellation route. Those are meaningful service details. Its contract, however, places important responsibilities on subscribers: automatic renewal, advance cancellation, required refill actions and restricted refunds. Conflicting branded-product prices and unclear application of minimum commitments make a product-specific written agreement especially important. The strongest basis for deciding whether to enroll is not the lowest headline figure, but a reconciled quote and terms naming the formulation, payment recipients, billing interval, minimum obligation and refund boundaries. Without those clarifications, the public documentation leaves material financial questions unresolved.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. Wilding et al. (2021): STEP 1 semaglutide trial ↗
  3. Shed — products/product/glp 1 lozenges ↗
  4. Shed — products/category/weight loss ↗
  5. Shed — official website ↗
  6. Shed — products/compounded tirzepatide injections ↗
  7. Shed — products/product/zepbound shed membership ↗
  8. Shed — resources/legal/terms ↗
  9. Shed — products/compounded semaglutide injections ↗
  10. Shed — products/foundayo ↗
  11. Shed — products/product/wegovy ↗
  12. Shed — products/womens hair solutions ↗
  13. Shed — products/product/glp 1 liquid drops ↗

Continue reading